2015至2017年中国临床实验室15项全程检验质量指标全国调查
该研究分析了2015至2017年中国25个省份76家临床实验室提交的15项质量指标(QIs)数据,QIs多选自国际临床化学与实验室医学联合会(IFCC)模型。结果显示多数QIs表现改善或稳定,分析前血培养污染缺陷率最高,实验室内部周转时间(TAT)大于检验前TAT,危急值通知表现最佳(6.0σ)。
要点
- 分析前阶段血培养污染缺陷百分比最大。
- 实验室内部TAT始终大于检验前TAT。
- 危急值通知及及时通知表现最佳,为6.0σ。
核心结论
- 质量指标的质量规范为实验室改进检验质量提供有用指导。
- 实验室应在全程检验过程各阶段采取持续质量改进措施。
研究设计与样本
- 2015至2017年中国25个省份76家临床实验室连续参与国家卫生健康委员会组织的质量指标调查。
- QIs多选自IFCC建立的通用质量指标模型,通过医疗质量控制数据收集系统提交数据。
主要发现
- 所有报告QIs表现随时间改善或至少保持稳定。
- 分析前阶段血培养污染缺陷百分比最大。
- 实验室内部TAT始终大于检验前TAT。
- 分析中阶段实验室间比对覆盖检验百分比相对较低。
- 危急值通知及及时危急值通知表现最佳,为6.0σ;错误实验室报告的中位σ水平为5.5σ至5.7σ。
关键数值与推荐
- QIs结果以百分比和σ报告,周转时间(TAT)以分钟计。
- 第25、50、75百分位数分别计算为三个质量规范水平。
临床怎么用
- 实验室可参考质量规范水平改进全程检验质量。
- 应关注分析前血培养污染、TAT及实验室间比对覆盖等薄弱环节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background As effective quality management tools, quality indicators (QIs) are widely used in laboratory medicine. This study aimed to analyze the results of QIs, identify errors and provide quality specifications (QSs) based on the state-of-the-art. Methods Clinical laboratories all over China participated in the QIs survey organized by the National Health Commission of People' Republic of China from 2015 to 2017. Most of these QIs were selected from a common model of QIs (MQI) established by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). All participants were asked to submit general information and original QIs data through a medical quality control data collection system. The results of QIs were reported in percentages and sigma, except turnaround time (TAT) which was measured in minutes. The 25th, 50th and 75th percentiles were, respectively, calculated as three levels of QSs, which were defined starting from the model proposed during the 1st Strategic Conference of the EFLM on "Defining analytical performance 15 years after the Stockholm Conference on Quality Specification in Laboratory Medicine". Results A total of 76 clinical laboratories from 25 provinces in China continuously participated in this survey and submitted complete data for all QIs from 2015 to 2017. In general, the performance of all reported QIs have improved or at least kept stable over time. Defect percentages of blood culture contamination were the largest in the pre-analytical phase. Intra-laboratory TAT was always larger than pre-examination TAT. Percentage of tests covered by inter-laboratory comparison was relatively low than others in the intra-analytical phase. The performances of critical values notification and timely critical values notification were the best with 6.0σ. The median sigma level of incorrect laboratory reports varied from 5.5σ to 5.7σ. Conclusions QSs of QIs provide useful guidance for laboratories to improve testing quality. Laboratories should take continuous quality improvement measures in all phases of total testing process to ensure safe and effective tests.
引用
- Duan M, Ma X, Fan J, et al. National surveys on 15 quality indicators for the total testing process in clinical laboratories of China from 2015 to 2017. Clin Chem Lab Med. 2018. PMID: 30016272. doi:10.1515/cclm-2018-0416
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。